Wei Wei

机构：Toyobo (Japan), Shanghai Jiao Tong University, Ruijin Hospital, Tianjin Medical University General Hospital, Hubei University of Arts and Science, Peking University Shenzhen Hospital, Shanghai First People's Hospital · ORCID：0000-0002-4195-8325

发表论文 133 篇 · 总被引 2855 次 · h-index 28

代表论文

• Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition) (2022 · Military Medical Research · 被引 145)
• Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies (2023 · Journal of Translational Medicine · 被引 49)
• PAI-1-driven SFRP2high cancer-associated fibroblasts hijack the abscopal effect of radioimmunotherapy (2025 · Cancer Cell · 被引 44)
• RETRACTED: Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats (2023 · Biomedicine & Pharmacotherapy · 被引 37)
• Establishment of papillary thyroid cancer organoid lines from clinical specimens (2023 · Frontiers in Endocrinology · 被引 33)
• A Novel Fibromodulin Antagonist Peptide RP4 Exerts Antitumor Effects on Colorectal Cancer (2023 · Pharmaceutics · 被引 16)